派克新材(605123.SH):擬出資5億元設立無錫全資子公司
格隆匯3月25日丨派克新材(605123.SH)公佈,2022年3月25日,無錫派克新材料科技股份有限公司第三屆董事會第三次會議審議並通過了《關於對外投資設立全資子公司的議案》。根據公司整體經營發展戰略規劃,公司以5億元人民幣出資設立全資子公司無錫派鑫航空科技有限公司(暫定名稱,最終以工商註冊登記為準),成立該公司主要的目的是:負責實施2022年度非公開發行股票募集資金投資項目--“航空航天用特種合金結構件智能生產線建設項目”。公司非公開發行募集資金到位之前,公司將根據項目進度的實際情況以自籌資金先行投入,待本次發行募集資金到位後將以募集資金予以置換。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.